MKI67 and metastatic malignant neoplasm in the lymph nodes: Monitoring aberrant 53BP1, particularly in conjunction with Ki67, may enhance the predictive accuracy for lymph node metastasis and vascular invasion, ultimately aiding the prognosis and management of patients with HPSCC.